The present document contains the report on the sixty-sixth session of the Commission on Narcotic Drugs, which was held from 13 to 17 March 2023. Chapter I contains the text of the resolutions and decisions adopted by the Commission or recommended by the Commission for adoption by the Economic and Social Council.
During its session, the Commission considered strategic management, budgetary and administrative questions; the implementation of the international drug control treaties; the follow-up to the implementation at the national, regional and international levels of all commitments, as reflected in the Ministerial Declaration of 2019, to address and counter the world drug problem; inter-agency cooperation and coordination of efforts in addressing and countering the world drug problem; recommendations of the subsidiary bodies of the Commission; matters relating to the Economic and Social Council, including the follow-up to and the review and implementation of the 2030 Agenda for Sustainable Development; and preparations for the midterm review, to be held in 2024, of progress made in implementing all international drug policy commitments, as reflected in the Ministerial Declaration of 2019, to address and counter the world drug problem.

The Commission decided to include 2-methyl-AP-237, etazene, etonitazepyne and protonitazene in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol. The Commission also decided to include ADB-BUTINACA, alpha-PiHP and 3-methylmethcathinone in Schedule II of the Convention on Psychotropic Substances of 1971. 

The Commission recommended the following draft decisions for adoption by the Economic and Social Council: “Report of the Commission on Narcotic Drugs on its sixty-sixth session and provisional agenda for its sixty-seventh session” and “Report of the International Narcotics Control Board”. The Commission adopted resolution 66/1, entitled “Preparations for the midterm review to be held during the sixty-seventh session of the Commission on Narcotic Drugs, in 2024”; resolution 66/2, entitled “Safe handling and disposal of synthetic drugs, their precursors and other chemicals used in the illicit manufacture of drugs”; resolution 66/3, entitled “Strengthening information-sharing to increase scientific evidence-based support for international scheduling and the effective implementation of international scheduling decisions”; and resolution 66/4, entitled “Promoting alternative development as a development-oriented drug control strategy that is sustainable and inclusive”.